666
Views
17
CrossRef citations to date
0
Altmetric
Review

Transglutaminase as a therapeutic target for celiac disease

, , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Xiaoxue Zhu, Xin-Huai Zhao, Qiang Zhang, Na Zhang, Olugbenga P. Soladoye, Rotimi E. Aluko, Yuhao Zhang & Yu Fu. (2023) How does a celiac iceberg really float? The relationship between celiac disease and gluten. Critical Reviews in Food Science and Nutrition 63:28, pages 9233-9261.
Read now
William P Katt, Cody Aplin & Richard A Cerione. (2022) Exploring the Role of Transglutaminase in Patients with Glioblastoma: Current Perspectives. OncoTargets and Therapy 15, pages 277-290.
Read now
Marialucia Gallorini & Simone Carradori. (2021) Understanding collagen interactions and their targeted regulation by novel drugs. Expert Opinion on Drug Discovery 16:11, pages 1239-1260.
Read now
Paolo D’Avino, Gloria Serena, Victoria Kenyon & Alessio Fasano. (2021) An updated overview on celiac disease: from immuno-pathogenesis and immuno-genetics to therapeutic implications. Expert Review of Clinical Immunology 17:3, pages 269-284.
Read now

Articles from other publishers (13)

Zhouzhou Yao, Yuhua Fan, Lizhen Lin, Rodney E. Kellems & Yang Xia. (2024) Tissue transglutaminase: a multifunctional and multisite regulator in health and disease. Physiological Reviews 104:1, pages 281-325.
Crossref
Sebastian Stricker, Jan de Laffolie, Klaus-Peter Zimmer & Silvia Rudloff. (2023) Inhibition of Transglutaminase 2 as a Therapeutic Strategy in Celiac Disease—In Vitro Studies in Intestinal Cells and Duodenal Biopsies. International Journal of Molecular Sciences 24:5, pages 4795.
Crossref
Laura Kivelä, Alberto Caminero, Daniel A. Leffler, Maria Ines Pinto-Sanchez, Jason A. Tye-Din & Katri Lindfors. (2020) Current and emerging therapies for coeliac disease. Nature Reviews Gastroenterology & Hepatology 18:3, pages 181-195.
Crossref
Gloria Serena, Paolo D'Avino & Alessio Fasano. (2020) Celiac Disease and Non-celiac Wheat Sensitivity: State of Art of Non-dietary Therapies. Frontiers in Nutrition 7.
Crossref
Mahesh Mohan, Chioma M. Okeoma & Karol Sestak. (2020) Dietary Gluten and Neurodegeneration: A Case for Preclinical Studies. International Journal of Molecular Sciences 21:15, pages 5407.
Crossref
Martin Stieler, Christian Büchold, Marisa Schmitt, Andreas Heine, Martin Hils, Ralf Pasternack & Gerhard Klebe. (2020) Structure‐Based Design of FXIIIa‐Blockers: Addressing a Transient Hydrophobic Pocket in the Active Site of FXIIIa. ChemMedChem 15:10, pages 900-905.
Crossref
Tiina Rauhavirta, Minna Hietikko, Teea Salmi & Katri Lindfors. (2016) Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review. Clinical Reviews in Allergy & Immunology 57:1, pages 23-38.
Crossref
Utpal Bose, Crispin A. Howitt & Michelle L. Colgrave. 2019. Encyclopedia of Food Chemistry. Encyclopedia of Food Chemistry 314 321 .
Jonas F Ludvigsson, Carolina Ciacci, Peter HR Green, Katri Kaukinen, Ilma R Korponay-Szabo, Kalle Kurppa, Joseph A Murray, Knut Erik Aslaksen Lundin, Markku J Maki, Alina Popp, Norelle R Reilly, Alfonso Rodriguez-Herrera, David S Sanders, Detlef Schuppan, Sarah Sleet, Juha Taavela, Kristin Voorhees, Marjorie M Walker & Daniel A Leffler. (2018) Outcome measures in coeliac disease trials: the Tampere recommendations. Gut 67:8, pages 1410-1424.
Crossref
R.A. Stein & D.E. Katz. 2017. Foodborne Diseases. Foodborne Diseases 475 526 .
Mateusz Kędzior, Rafał Seredyński & Jan Gutowicz. (2016) Microbial inhibitors of cysteine proteases. Medical Microbiology and Immunology 205:4, pages 275-296.
Crossref
M. Schumann, S. Daum & B. Siegmund. (2015) Pathophysiologie der ZöliakiePathophysiology of celiac disease. Der Gastroenterologe 10:6, pages 464-472.
Crossref
Léa M.M. Costes, Bertrand Meresse, Nadine Cerf-Bensussan & Janneke N. Samsom. (2015) The role of animal models in unravelling therapeutic targets in coeliac disease. Best Practice & Research Clinical Gastroenterology 29:3, pages 437-450.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.